Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations

Cefiderocol is a novel siderophore cephalosporin antibacterial with activity against carbapenem-resistant Gram-negative bacteria including Pseudomonas aeruginosa. We report a medically complex patient treated with compassionate use cefiderocol for an empyema caused by extensively drug-resistant P. a...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Wesley D. Kufel, Jeffrey M. Steele, Scott W. Riddell, Zachary Jones, Pegah Shakeraneh, Timothy P. Endy
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2020-01-01
Schriftenreihe:	IDCases
Schlagworte:	Cefiderocol Pseudomonas aeruginosa Antibacterial resistance Siderophore Susceptibility testing
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2214250920301712
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!